ad-td-nsil12
Biologicalexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 4, 2023 (NCT05717699)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07126990 | Phase 1/Phase 2 (Phase 2) | Feb 12, 2025 | Government of China |
| NCT05717699 | Phase 1 | Jan 4, 2023 | Capital Medical University |
| NCT05717712 | Phase 1 | Jan 4, 2023 | Capital Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 2 | 1 | 2023 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1